Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Individualized Treadmill Walking Speeds Followed by Cognitive Training on HRV, Gait, and Motor-Cognitive in Older Adults With Type 2 Diabetes: A Randomized Controlled Trial With 4-Week Retention Follow-up

NCT07920510 is registered in ClinicalTrials.gov with University of Phayao as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07920510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Individualized Treadmill Walking Speeds Followed by Cognitive Training on HRV, Gait, and Motor-Cognitive in Older Adults With Type 2 Diabetes: A Randomized Controlled Trial With 4-Week Retention Follow-up
Lead sponsor
University of Phayao
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 22, 2026
Completion date
October 29, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 3 arms.

  • Arm 1 - Experimental: Higher-Speed Treadmill Walking + Cognitive Training ExperimentalCognitive training, Individualized Higher-Speed Treadmill Walking

    Participants perform individualized treadmill walking prescribed relative to their baseline preferred walking speed (PWS), using 120-130% PWS as the higher-speed condition. Treadmill walking is performed under supervision three times per week for 6 weeks. After completion of the treadmill walking component, participants perform a separate seated cognitive training session. Cognitive training is not performed concurrently with treadmill walking because of safety considerations related to fall risk in older adults. After the 6-week intervention, participants receive no supervised treadmill or cognitive training for 4 weeks before the retention assessment.

  • Arm 2 - Active Comparator: Preferred-Speed Treadmill Walking + Cognitive Training Active comparatorCognitive training, Individualized Preferred-Speed Treadmill Walking

    Participants perform individualized treadmill walking at 100% of their baseline preferred walking speed (PWS) under supervision three times per week for 6 weeks. After completion of treadmill walking, participants perform the same separate seated cognitive training used in the higher-speed group. Cognitive training is not performed concurrently with treadmill walking. After the 6-week intervention, participants receive no supervised treadmill or cognitive training for 4 weeks before the retention assessment.

  • Arm 3 - Active Comparator: Usual Activity and Fall-Prevention Health Education Active comparatorFall-Prevention Health Education

    Participants continue their usual daily activities and do not receive supervised treadmill walking or cognitive training. Participants receive standardized health education on fall prevention. Outcomes are assessed according to the same schedule as the two treadmill-training groups.

Primary endpoints

Registered primary outcome measures; 4 primary.

  • Change in Standard Deviation of Normal-to-Normal Intervals (SDNN) Baseline and immediately after the 6-week intervention.

    Resting heart rate variability is assessed using the SA-3000P heart rate variability analyzer under standardized seated resting conditions. SDNN is the standard deviation of normal-to-normal R-R intervals and is reported in milliseconds (ms). Higher SDNN values indicate greater overall heart rate variability.

  • Change in Root Mean Square of Successive Differences (RMSSD) Baseline and immediately after the 6-week intervention.

    Resting heart rate variability is assessed using the SA-3000P heart rate variability analyzer under standardized seated resting conditions. RMSSD is calculated from successive normal-to-normal R-R interval differences and is reported in milliseconds (ms). RMSSD is used as an index of short-term cardiac vagal modulation.

  • Change in Timed Up and Go Dual-Task Test Completion Time Baseline and immediately after the 6-week intervention.

    Motor-cognitive mobility is assessed using the Timed Up and Go Test performed under a concurrent secondary-task condition. Participants rise from a chair, walk 3 meters, turn, return, and sit down while carrying a cup of water. Completion time is recorded in seconds. A shorter completion time indicates better performance under dual-task conditions.

  • Change in Figure-of-8 Walk Dual-Task Test Completion Time Baseline and immediately after the 6-week intervention.

    Dual-task walking performance is assessed using the Figure-of-8 Walk Test under a concurrent secondary-task condition. Participants walk a figure-of-8 course around two markers while carrying a cup of water. Completion time is recorded in seconds. A shorter completion time indicates better performance.

Lead sponsor's other trials

University of Phayao, most recent start first.

Similar trials

Same condition (Diabetes Mellitus, Type 2) and phase, most recent start first.